EW
Eric Warren (Chief Commercial Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Mineralys Therapeutics, Inc. (MLYS). The largest single filing was $2.7M of MLYS (104,124 sh × $25.90, as filed), executed Jun 26. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
4
0 buys · 4 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$3.3M
shares × price, as filed
Last traded
Sep 21
Filed Sep 22
Median ADV $38.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $3.3M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
4 filings
Sector per market data · by filing · past 12 months
Most traded names
MLYS
Mineralys Therapeutics, Inc.
MLYS · 0 buys · 4 sells
4 filings
Recent filings
MLYSSALE
Mineralys Therapeutics, Inc.
View filing →
$209K7,438 sh × $28.12
Exec Sep 21
Filed Sep 22 · 6:48 PM ET MLYSSALE Mineralys Therapeutics, Inc. View filing → $193K
7,437 sh × $25.98
Exec Aug 21
Filed Aug 25 · 5:16 PM ET MLYSSALE Mineralys Therapeutics, Inc. View filing → $200K
7,438 sh × $26.87
Exec Jul 21
Filed Jul 23 · 6:39 PM ET MLYSSALE Mineralys Therapeutics, Inc. View filing → $2.7M
104,124 sh × $25.90
Exec Jun 26
Filed Jun 30 · 5:30 PM ET